column
    Long-Term Survival in Lung Cancer: Towards a Cure
    LIU Si-yang, WU Yi-long
    2021, 21(4): 193-196. DOI: 10.12019/j.issn.1671-5144.2021.04.001
    Abstract PDF
    Five-Year Outcomes From KEYNOTE-024: Pembroli-zumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%
    LU Shun
    2021, 21(4): 197-201. DOI: 10.12019/j.issn.1671-5144.2021.04.002
    Abstract PDF
    Pembrolizumab in Previously Untreated Chinese Patients With PD-L1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer: KEYNOTE-042 China Extension Study
    ZHOU Qing
    2021, 21(4): 202-207. DOI: 10.12019/j.issn.1671-5144.2021.04.003
    Abstract PDF
    Pembrolizumab With or Without Chemotherapy as First-Line Therapy for Advanced Nonsquamous NSCLC: Comments to Long-Term Overall Survival Data of Cohort G in KEYNOTE-021 Study
    ZHOU Jian-ya, ZHOU Jian-ying
    2021, 21(4): 208-213. DOI: 10.12019/j.issn.1671-5144.2021.04.004
    Abstract PDF
    Pooled Analysis of Pembrolizumab Plus Chemotherapy in Advanced Non-Small Cell Lung Cancer Patients Without Tumor PD-L1 Expression
    HUANG Cheng
    2021, 21(4): 214-219. DOI: 10.12019/j.issn.1671-5144.2021.04.005
    Abstract PDF
    Summary of Pathological Morphology and Immunohistochemical Characteristics of 23 Cases of Superficial Myofibroblastoma of Female Genital Tract
    FENG Hai-jia, LI Chuan, YANG Jin-hua
    2021, 21(4): 220-224. DOI: 10.12019/j.issn.1671-5144.2021.04.006
    Abstract PDF
    Application of Pathological Complete Response in Tumor Clinical Trials
    ZHUO Jun-cheng, GONG Xiao, DU Hai-jian, ZHANG Sheng-peng
    2021, 21(4): 225-231. DOI: 10.12019/j.issn.1671-5144.2021.04.007
    Abstract PDF
    The Application Value of Composite Multimodal Ultrasound Imaging in Differentiating Malignant From Benign ACR BI-RADS Category 4 Nodular Breast Lesions
    XIAO Mei-hua, PEI Shu-fang, CONG Shu-zhen, LIU Juan-juan, FENG Zhan-wu, GUO Yu-ping
    2021, 21(4): 232-239. DOI: 10.12019/j.issn.1671-5144.2021.04.008
    Abstract PDF
    An Overview and Interpretation of Important Clinical Studies on Non-Small Cell Lung Cancer in 2020
    LIU Si-yang, ZHANG Jia-tao, WU Yi-long
    2021, 21(4): 240-249. DOI: 10.12019/j.issn.1671-5144.2021.04.009
    Abstract PDF
    Treatment Strategies of Slowly Progressive Advanced Non-Small Cell Lung Cancer
    LIN Jun-tao, DONG Song, YANG Xue-ning, WU Yi-long
    2021, 21(4): 250-256. DOI: 10.12019/j.issn.1671-5144.2021.04.010
    Abstract PDF